A survey on the adverse reactions of SARS-CoV-2 vaccine in patients with inflammatory bowel disease
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0006839
- Lead Sponsor
- Keimyung University Dongsan Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 600
1. Patient group: IBD patients aged between 20 and 80 years, who have been inoculated with second SARS-CoV-2 vaccine for more than 1 week
2. Health control group: Persons aged between 20 and 80 who have been inoculated with second SARS-CoV-2 vaccine for more than 1 week
3. A participant who has signed a written consent form after hearing the explanation of the purpose and method of the clinical research
1. Patient group: Patients with IBD for whom information on adverse reactions related to vaccination cannot be obtained
2. Healthy control group: Healthcare workers for whom information on adverse reactions related to vaccination cannot be obtained
3. IBD patients with acute illness who have been hospitalized within 4 weeks of vaccination
4. IBD patients who have had surgery within 3 months
5. Subjects who do not agree to participate in the study
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vaccine-related adverse events
- Secondary Outcome Measures
Name Time Method IBD-related symptoms